<DOC>
	<DOCNO>NCT00332293</DOCNO>
	<brief_summary>The purpose study determine whether AL-15469A safe effective treatment bacterial conjunctivitis .</brief_summary>
	<brief_title>AL-15469A Treatment Bacterial Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Bacterial</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>sign symptom bacterial conjunctivitis Other protocoldefined inclusion criterion may apply 1 mo . age Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>